Vascular endothelial growth factors and liver diseases

Hepato-Gastroenterology

Volumn 48, Issue 40, 2001, Pages 1145-1148

  Shi, B ^a   Wang, X ^a   Yang, Z ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Hepatitis; Hepatocellular carcinoma; Liver cirrhosis; VEGF

Indexed keywords

MESSENGER RNA; PROTEIN; VASCULOTROPIN;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RISK; CHRONIC HEPATITIS; DIGESTIVE SYSTEM CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ACUTE DISEASE; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; ENDOTHELIAL GROWTH FACTORS; HEPATITIS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; LYMPHOKINES; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034887583     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
2. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
3. Expression of vascular endothelial growth factor in human hepatocellular carcinoma
4. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas
5. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
6. The biology of vascular endothelial growth factor
7. Regulation of vascular endothelial growth factor in cardiac myocytes
8. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
9. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
10. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
11. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
12. Differential regulation of vascular endothelial growth factor and its receptor fms-like-tyrosine kinase is mediated by nitric oxide in rat renal mesangial cells
13. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis
14. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
15. Vascular endothelial growth factor is induced in response to transforming growth factor-B in fibroblastic and epithelial cells
16. Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C
17. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis
18. Significance of angiogenic factors in liver metastatic tumors originating from colorectal cancers
19. Serum vascular endothelial growth factor levels in various liver diseases
20. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver
21. Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma
22. Hemangiopericytoma of the liver: Immunohistochemical observations, expression of angiogenic factors, and review of the literature
23. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma
24. The mechanisms of hepatic sinusoidal endothelial cell regeneration: A possible communication system associated with vascular endothelial growth factor in liver cells
25. Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma
26. Expression of vascular endothelial growth factor in normal liver and hepatocellular carcinoma: An immunohistochemical study
27. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor
28. Vascular endothelial growth factor tightly regulates in vivo development of murine hepatocellular carcinoma cells
29. Anti-tumor and anti-metastatic effects of human-vascular-endothelial-growth-factor-neutralizing antibody on human colon and gastric carcinoma xenotransplanted orthotopically into nude mice
30. Antitumor effect of a neutralizing antibody to vascular endothelial growth factor on liver metastasis of endocrine neoplasm
31. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
32. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer
33. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer
34. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
35. Effects of cytokines on the liver
36. Hypoxia, a novel inducer of acute-phase gene expression in a human hepatoma cell line
37. Tumors cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
38. Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma
39. Molecular mechanisms of liver fibrogenesis - A homage to the role of activated fat-storing cells
40. Expression of vascular endothelial growth factor in renal vascular disease and renal allograft